Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia
暂无分享,去创建一个
R. Collins | H. Kantarjian | M. Tallman | C. Dinardo | S. de Botton | M. Frattini | D. Pollyea | E. Attar | S. Agresta | E. Stein | A. Stein | K. Macbeth | Qiang Xu | A. Tosolini | W. See